KCK LTD. - Q3 2023 holdings

$70.4 Million is the total value of KCK LTD.'s 3 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
NPCE  NEUROPACE INC$54,693,410
+116.7%
5,621,1110.0%77.70%
+96.4%
SellSIGHT SCIENCES INC$15,659,938
-59.3%
4,646,866
-0.1%
22.25%
-63.1%
 AILERON THERAPEUTICS INC$33,958
-15.1%
22,3410.0%0.05%
-23.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-01
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SIGHT SCIENCES, INC.8Q3 202387.4%
NEUROPACE, INC.8Q3 202377.7%
AILERON THERAPEUTICS, INC.4Q3 20220.3%
AILERON THERAPEUTICS INC4Q3 20230.1%
IMMUNIC, INC.3Q2 20220.8%

View KCK LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
KCK LTD. Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VITAL THERAPIES INCFebruary 13, 20172,788,1818.7%

View KCK LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42023-12-01
1442023-11-29
42023-11-29
13F-HR2023-11-01
13F-HR2023-07-25
13F-HR2023-05-05
SC 13G2023-02-13
13F-HR2023-01-31

View KCK LTD.'s complete filings history.

Compare quarters

Export KCK LTD.'s holdings